Showing 1 - 11 results of 11 for search 'Neil J Shah', query time: 0.11s
Refine Results
-
1
-
2
Product review on the Anti-PD-L1 antibody atezolizumab by Neil J. Shah, William J. Kelly, Stephen V. Liu, Karin Choquette, Alexander Spira
Published 2018-02-01
Article -
3
-
4
-
5
-
6
Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis by Dongyu Zhang, Neil J. Shah, Michael Cook, Matthew Blackburn, Michael T. Serzan, Shailesh Advani, Arnold L. Potosky, Subha Madhavan, Anas Belouali, Michael B. Atkins, Dejana Braithwaite
Published 2021-12-01
Article -
7
Real-world Treatment Patterns and Clinical Outcomes for Metastatic Renal Cell Carcinoma in the Current Treatment Era by Neil J. Shah, Sneha D. Sura, Reshma Shinde, Junxin Shi, Puneet K. Singhal, Nicholas J. Robert, Nicholas J. Vogelzang, Rodolfo F. Perini, Robert J. Motzer
Published 2023-03-01
Article -
8
Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors:... by Dongyu Zhang, Neil J. Shah, Michael Cook, Matthew Blackburn, Michael T. Serzan, Shailesh Advani, Arnold L. Potosky, Subha Madhavan, Anas Belouali, Michael B. Atkins, Dejana Braithwaite
Published 2022-09-01
Article -
9
615 The impact of gender including female menopausal status on the safety and efficacy of immune checkpoint inhibitors by Michael B Atkins, Neil J Shah, Jacob Zaemes, Andrew Pecora, Shaked Lev Ari, Lauren Pascual, Brittany Sinclaire, Alexandra DellaPia, Rachel A Zemel, Adil Alaoui, Andrew Ip, Deniz Ozisik, Ming Tan
Published 2023-11-01Article -
10
1244 Polarized immune responses reveal actionable therapeutic targets in cutaneous adverse events to checkpoint inhibitors by Mario E Lacouture, Neil J Shah, Lukas kraehenbuehl, Stephanie Gu, Andrea P Moy, Elena Goleva, Kwami Ketosugbo, Tara Maier, Trina Salvador, Ryan Weight, Veronica Rotemberg, Jeffrey A Kern, Donald Y Leung
Published 2023-11-01Article -
11
1418 Treatment-free survival in patients with advanced melanoma and non-small cell lung cancer receiving immune checkpoint inhibitors: real-world outcomes over a 3-year timespan by Samir Gupta, Michael B Atkins, Meredith Regan, Neil J Shah, Jacob Zaemes, Opeyemi A Jegede, Shaked Lev Ari, Lauren Pascual, Natali Arias-Orozco, Brittany Sinclaire, Alexandra DellaPia, Rachel A Zemel, Yili Zhang, Adil Alaoui, Andrew Ip
Published 2023-11-01Article